Shuang Wang

8PUBLICATIONS
64CO-AUTHORS
Predictive and prognostic markersMedical infection agents (incl. prions)Cancer therapy (excl. chemotherapy and radiation therapy)Medical biochemistry - lipidsCounselling, wellbeing and community services
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Jan 21, 2026
Anti-FAP CAR T cells produced in vivo reduce fibrosis and restore liver homeostasis in metabolic dysfunction-associated steatohepatitis.

Chittampalli N Yashaswini, Bruno Cogliati, Tianyue Qin

|Mar 21, 2025
Mannose reduces fructose metabolism and reverses MASH in human liver slices and murine models in vivo.

John G Hong, Joshaya Trotman, Yvette Carbajal

|Mar 10, 2025
In vivo anti-FAP CAR T therapy reduces fibrosis and restores liver homeostasis in metabolic dysfunction-associated steatohepatitis.

Chittampalli N Yashaswini, Bruno Cogliati, Tianyue Qin

|Feb 19, 2024
Stellate cell-specific adhesion molecule protocadherin 7 regulates sinusoidal contraction.

James K Carter, Ming-Chao Tsai, Nicholas Venturini

|Oct 04, 2023
Found in translation-Fibrosis in metabolic dysfunction-associated steatohepatitis (MASH).

Shuang Wang, Scott L Friedman

Pageof 2